Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (21-30 of 266) with videos related to

Pageof 27
Sort By:
Current Psychiatry Reports|January 30, 2002
Depression in Parkinson's diseaseTheresa A Zesiewicz, Robert A Hauser
The Neurologist|May 15, 2007
Advances in the pharmacologic management of early Parkinson diseaseRobert A Hauser, Theresa A Zesiewicz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 8, 2020
Medical Management and Prevention of Motor Complications in Parkinson's DiseaseStephen D Aradi, Robert A Hauser
Expert Opinion on Pharmacotherapy|November 24, 2015
Carbidopa levodopa enteral suspensionLauren C Seeberger, Robert A Hauser
Expert Review of Neurotherapeutics|July 11, 2009
Levodopa/carbidopa/entacapone in Parkinson's diseaseLauren C Seeberger, Robert A Hauser
Expert Opinion on Pharmacotherapy|July 13, 2017
Valbenazine for the treatment of tardive dyskinesiaLauren C Seeberger, Robert A Hauser
Neuropharmacology|October 16, 2007
Optimizing bioavailability in the treatment of Parkinson's diseaseLauren C Seeberger, Robert A Hauser
European Neurology|May 16, 2008
Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatmentsElmyra V Encarnacion, Robert A Hauser
CNS Drugs|May 31, 2003
Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?Theresa A Zesiewicz, Robert A Hauser
Neurology|May 24, 2006
Clinical trials aimed at detecting neuroprotection in Parkinson's diseaseRobert A Hauser, Theresa A Zesiewicz
Pageof 27

Showing results (21-30 of 266) with videos related to

Sort By:
Pageof 27
Current Psychiatry Reports|January 30, 2002
Depression in Parkinson's diseaseTheresa A Zesiewicz, Robert A Hauser
The Neurologist|May 15, 2007
Advances in the pharmacologic management of early Parkinson diseaseRobert A Hauser, Theresa A Zesiewicz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 8, 2020
Medical Management and Prevention of Motor Complications in Parkinson's DiseaseStephen D Aradi, Robert A Hauser
Expert Opinion on Pharmacotherapy|November 24, 2015
Carbidopa levodopa enteral suspensionLauren C Seeberger, Robert A Hauser
Expert Review of Neurotherapeutics|July 11, 2009
Levodopa/carbidopa/entacapone in Parkinson's diseaseLauren C Seeberger, Robert A Hauser
Expert Opinion on Pharmacotherapy|July 13, 2017
Valbenazine for the treatment of tardive dyskinesiaLauren C Seeberger, Robert A Hauser
Neuropharmacology|October 16, 2007
Optimizing bioavailability in the treatment of Parkinson's diseaseLauren C Seeberger, Robert A Hauser
European Neurology|May 16, 2008
Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatmentsElmyra V Encarnacion, Robert A Hauser
CNS Drugs|May 31, 2003
Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?Theresa A Zesiewicz, Robert A Hauser
Neurology|May 24, 2006
Clinical trials aimed at detecting neuroprotection in Parkinson's diseaseRobert A Hauser, Theresa A Zesiewicz
Pageof 27